|
1
|
- Glenn Schmidt, Rob Yemm, Kirby Childs, Jim O’Callaghan and Kim Hossner
|
|
2
|
- American Meat Institute wanted to follow up on report from Tam Garland
and Nate Bauer entitled: Brain Emboli in Lungs of Cattle After Stunning
- Lancet 1996. 348:610
|
|
3
|
- Goal: To maintain consumer
confidence in products derived from Advanced Meat Recovery (AMR) systems
and provide industry with an objective scientific means of complying
with existing regulations.
|
|
4
|
- Carcass Split - Proper carcass split is critical step.
|
|
5
|
|
|
6
|
- Kill Floor
- Assigned Worker to vacuum spinal cord from spinal canal.
- Second employee, visual check and remove any remaining with hand
scraper
- All Miss-splits - opened and spinal cord removed.
- Any failed AFSL for spinal cord removal, lot will be tagged and checked
100%.
- Second saw located in Sales Cooler.
|
|
7
|
|
|
8
|
|
|
9
|
|
|
10
|
|
|
11
|
|
|
12
|
- Zero tolerance for Spinal Cord presence in Bones
- Continual monitoring of bones going to Protecon by production
employees.
- Any bone with evidence of spinal cord is removed and sent to inedible
rendering.
- Any bones that have been inked indicating miss-split are removed and
sent to inedible rendering.
|
|
13
|
|
|
14
|
- Once per hour, Technical Services personnel will check 10 neck-bones for
evidence of spinal cord.
- Times and results will be recorded.
- If any spinal cord is found:
- Immediate notification of; 1. Technical Services; 2. Trim and Grind;
3. Fab Supt.; 4. Rendering
- All Protecon production back to last clear check will then be tagged,
sent to inedible rendering.
- All failures will be documented.
|
|
15
|
|
|
16
|
|
|
17
|
- Elimination of Central Nervous Tissue from products.
- Carcass Splitting
- Spinal Cord Elimination
- Verification of Program
|
|
18
|
- Glial fibrillary acidic protein
- Jim O ’Callaghan
- NIOSH
- Morgantown, WV
|
|
19
|
|
|
20
|
- An Enzyme Linked Immunosorbant Assay for Glial Fibrillary Acidic Protein
as an Indicator of the Presence of Brain or Spinal Cord in Meat
- J. Food Protection 1999, 62:294
|
|
21
|
|
|
22
|
|
|
23
|
|
|
24
|
|
|
25
|
|
|
26
|
|
|
27
|
|
|
28
|
|
|
29
|
|
|
30
|
|
|
31
|
|
|
32
|
|
|
33
|
|
|
34
|
|
|
35
|
- Spinal cord
2,000
- Brain 600
- Sciatic 12
- Cervical ganglia
2
- Cuts
0-18
- Bone saw dust
0-11
- Heart blood clot
0-7
|
|
36
|
|
|
37
|
|
|
38
|
|
|
39
|
|
|
40
|
|
|
41
|
- Average:
- Range :
- % < 1.0 ng/mg:
|
|
42
|
- Average:
- Range :
- % < 1.0 ng/mg:
|
|
43
|
- Average:
- Range :
- % < 1.0 ng/mg:
|
|
44
|
- Average:
- Range :
- % < 1.0 ng/mg:
|
|
45
|
- Average:
- Range :
- % < 1.0 ng/mg:
|
|
46
|
|
|
47
|
|
|
48
|
- Industry Trade Associations will
continue to assist plants in implementing GMP’s for spinal cord removal.
- All GFAP analytical methods can be used to detect CNS tissue in AMR
products and to verify spinal cord removal procedures have been properly
implemented.
|
|
49
|
- Considerable sample to sample variation exists for all analytical
methods which dictates test results be charted over time to establish
appropriate process control limits.
- AMR and Ground Chuck with AMR included, show mean GFAP levels below those found in
various muscle cuts.
|
|
50
|
|
|
51
|
|